ftInvstr
ADVENZYMES · Basic Materials ₹281.15 -1.07% Mkt Cap ₹3157 Cr

ADVENZYMES

Basic Materials Specialty Chemicals
₹281.15
-1.07% today · 30d +5.3%
as of 2026-11-09
Price · Daily Candles
“Advent Enzymes: Quarterly Profit Surges 69% on Strong Revenue, But FIIs Trim Holdings”
Advent Enzymes delivered impressive Q4 2026 results, with net profit soaring by 69.31% YoY to ₹45 Cr on a 21.65% increase in revenue to ₹203 Cr. The company's TTM PE of 25.0 is significantly lower than some sector peers, yet its ROCE of 14.0% lags market leaders.
BULL CASE
+Q4 2026 net profit surged by an impressive 69.31% YoY, reaching ₹45 Cr.
+Quarterly revenue for Q4 2026 increased by 21.65% YoY to ₹203 Cr.
+Annual net profit grew by 29.58% YoY to ₹174 Cr for the year ended March 2026.
+Promoter shareholding increased by 0.22% QoQ to 43.26% as of March 2026.
+The predicted sales growth for the stable 7-year horizon (sales_1y_stable_7y) shows a neutral rank of 0.482.
BEAR CASE
−FIIs decreased their stake by 0.37% QoQ to 25.49% in March 2026.
−DIIs also reduced their holding by 0.10% QoQ to 5.41% as of March 2026.
−The intrinsic value of ₹73.92 suggests the stock is currently overvalued with a -80.3% margin of safety.
−The 5-year CAGR for net profit is a modest 2.77% ending March 2026.
−Free cash flow growth projections (fcf_1y_recent_2y) are weak, ranked at 0.351.
⟳ What Changed
₹ Latest Earnings · Q ending 2026-03-31
REVENUE
₹203 Cr
+21.65% YoY
NET PROFIT
₹45 Cr
+69.31% YoY
OPM
33.46%
+2.56pp YoY
EPS
₹3.84
PE 25.0
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-3.8%, h2=+0.0%, h3=-0.0% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
Advent Enzymes, with a TTM PE of 25.0 and ROCE of 14.0%, trades at a significant discount to sector giants like Asian Paints (PE 69.19, ROCE 28.61%) but lags in profitability metrics.
PEERPEROCE %
ADVENZYMES25.014.0
ASIANPAINT69.1928.61
PIDILITIND61.4530.22
FLUOROCHEM76.1315.03
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
63
SCORE / 100
Overall
6-axis composite of the sections below.
Performance NEUTRAL 40
Valuation REASONABLE 60
Growth STRONG 70
Profitability HIGH 75
Technicals NEUTRAL 65
Risk LOW 70
Key Stats
TTM PE
25.0
P/B
2.58
52W HIGH
₹419.0
OFF HIGH
-32.9%
DIV YIELD
1.38%
MKT CAP
₹3157 Cr
◉ Active Signals
MACDBullish3.4708
RSI(14)Neutral55.54
Street Consensus
1 analyst
₹370.0
mean target
Low ₹370.0Now ₹281.15High ₹370.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold ADVENZYMES and at what entry.

Sign up freeSign in